Latest Articles
Trump Says Iran Deal to Be Signed Sunday, Tehran Questions Timing
President Trump announced that a deal to halt the Iran war and reopen the Strait of Hormuz would be signed on Sunday, but Iranian officials cast doubt on the timing, saying a signing may take place in the coming days. The discrepancy highlights fragile diplomacy, competing domestic narratives and high strategic stakes for global energy and security.
Surprising Molecular Link Between Cancer and Alzheimer’s
New research reveals overlapping molecular and cellular pathways between cancer and Alzheimer’s disease, challenging long-held assumptions and opening fresh avenues for diagnosis and treatment. This feature explores the science, the paradoxical epidemiology, and what the discovery means for patients and researchers.
Strength Training Sweet Spot for a Longer Life
New evidence and expert synthesis suggest there is a practical, science-backed sweet spot for strength training that maximizes longevity benefits without unnecessary time or risk. This article explains the physiology, the dose-response, practical programs for different ages, and clear guidance to make strength training sustainable and effective.
Scientists Identify Brain Chemical That Helps Break Bad Habits
Researchers have identified a neuromodulator that appears to enable the brain to restructure entrenched routines by boosting plasticity in decision-making circuits. The finding explains why certain behaviors are stubborn and points to practical ways—behavioral and lifestyle-based—to accelerate habit change.
BDNF and Breaking Bad Habits: The Brain Chemical That Helps
New research highlights the role of brain-derived neurotrophic factor (BDNF) in weakening old habits and supporting new behaviors. This feature explains the neuroscience, practical ways to support BDNF, and a realistic roadmap to change.
Scientists Identify New Alzheimer’s Trigger — Drug That Blocks It
Researchers report discovery of a previously overlooked molecular trigger that accelerates Alzheimer’s pathology and a candidate drug that halts that cascade in preclinical studies, opening a new therapeutic direction and promising earlier intervention strategies.